Fiscal Year: January - December
ICON Public Limited Company (ICLR), listed on the NASDAQ, has a market capitalization of $11.18B. As of Jun 22, 2026, the stock is trading at $146.00 per share@else an unavailable price , offering investors a clear view of its current market value. ICON Public Limited Company is a prominent player in the industry sector, attracting both institutional and retail investors due to its performance and potential.
With a P/E ratio of 50.34, investors can assess the stock's valuation in comparison to its earnings. A P/E ratio is a crucial indicator for value investors, showing whether the stock is over or undervalued relative to its current earnings. ICON Public Limited Company also offers a dividend yield of N/A , making it an attractive option for income-focused investors who seek regular dividends.
Our Discounted Cash Flow (DCF) analysis reveals that ICON Public Limited Company (ICLR) may be undervalued compared to its intrinsic worth. However, to see the exact DCF fair value, please Login or Upgrade for access.
The proprietary SS Score for ICON Public Limited Company is a unique metric that analyzes the company's financial health and growth potential. The score takes into account critical factors such as revenue growth, net income, free cash flow (FCF) compound annual growth rate (CAGR), the trend of shares outstanding, and the debt-to-FCF ratio. This helps investors to make a more informed decision, as an undervalued stock might still have poor financial fundamentals.
To view the detailed SS Score for ICON Public Limited Company, Login or Upgrade for access.
The Price to Free Cash Flow (P/FCF) ratio for ICON Public Limited Company is 12.97, offering insights into how much investors are paying for the company's free cash flow. A lower P/FCF ratio typically suggests that the stock is undervalued, while a higher ratio may indicate overvaluation.
In summary, ICON Public Limited Company (ICLR) has shown consistent financial performance, as illustrated by the financial charts above, which track its revenue growth, net income, free cash flow, and shares outstanding over the past several years. These metrics provide investors with key insights into the company's past and projected future performance. Investors should use the SS Score alongside the DCF Fair Value to make better-informed decisions about whether to buy or hold the stock.
*This analysis is for informational purposes only and does not constitute investment advice. Always read the company's 10-K filings and do your own research before making any investment decisions.
Whether ICON Public Limited Company (ICLR) is a good stock to buy depends on various factors, including its financial health, market conditions, and your investment strategy. Our analysis indicates that the stock may be undervalued compared to its intrinsic value. However, it is important to assess the SS Score and review the company's fundamentals before making any investment decisions.
The fair value of ICON Public Limited Company (ICLR) is determined through our Discounted Cash Flow (DCF) analysis. This value represents the intrinsic worth of the stock based on its expected future cash flows. To view the specific fair value, consider subscribing to our service for complete access.
The SS Score is a proprietary financial quality metric that assesses factors such as revenue growth, net income, free cash flow growth, and debt levels. It helps investors evaluate the overall financial health of ICON Public Limited Company. To access the full SS Score, consider upgrading your subscription.
ICON Public Limited Company is a significant player in the industry sector, with a market capitalization of $11.18B and a competitive P/E ratio of 50.34. Investors should compare these metrics with industry peers to gauge whether ICON Public Limited Company is outperforming or underperforming within its sector.
DUBLIN--(BUSINESS WIRE)--ICON Schedules First Quarter 2026 Earnings Conference Call.
TD Cowen raised the firm’s price target on Icon (ICLR) to $164 from $120 and keeps a Buy rating on the shares. The firm sees the company’s investigation conclusion as…
BofA raised the firm’s price target on Icon (ICLR) to $125 from $105 and keeps an Underperform rating on the shares. Following the Q4 report, the firm believes the company…
Truist raised the firm’s price target on Icon (ICLR) to $159 from $139 and keeps a Hold rating on the shares after the company’s Q4 results and initial FY26 outlook.
RBC Capital raised the firm’s price target on Icon (ICLR) to $126 from $123 and keeps a Sector Perform rating on the shares. The company’s Q4 earnings and restated financials…
Jefferies raised the firm’s price target on Icon (ICLR) to $165 from $135 and keeps a Buy rating on the shares. Gross bookings momentum and the accounting investigation outcome were…
BMO Capital analyst Sean Dodge raised the firm’s price target on Icon (ICLR) to $160 from $130 and keeps an Outperform rating on the shares. The firm is updating its…
JPMorgan raised the firm’s price target on Icon (ICLR) to $130 from $120 and keeps a Neutral rating on the shares post the Q4 report. The company reported strong bookings…
Citi analyst Patrick Donnelly raised the firm’s price target on Icon (ICLR) to $140 from $120 and keeps a Neutral rating on the shares.
Baird raised the firm’s price target on Icon (ICLR) to $168 from $142 and keeps an Outperform rating on the shares.
Barclays raised the firm’s price target on Icon (ICLR) to $150 from $120 and keeps an Equal Weight rating on the shares following the fiscal Q4 report. The estimate “reset…
Leerink raised the firm’s price target on Icon (ICLR) to $145 from $125 and keeps a Market Perform rating on the shares.
Reports Q4 revenue $2.11B, consensus $1.99B. CEO, Mr. Barry Balfe commented, “ICON (ICLR) demonstrated continued commercial momentum through the fourth quarter, underpinned by disciplined execution ag...
DUBLIN--(BUSINESS WIRE)--ICON Reports Fourth Quarter and Full Year 2025 Results and Provides Outcome of Audit Committee Investigation.
BofA raised the firm’s price target on Icon (ICLR) to $105 from $90 and keeps an Underperform rating on the shares. The firm is updating its Q4, FY26 and FY27…
DUBLIN--(BUSINESS WIRE)--ICON Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call and Acknowledges Receipt of Deficiency Notice from Nasdaq.
DUBLIN & SAN ANTONIO--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced the expansion of its early phase capabilities with the opening of a new,...
Philadelphia, PA, May 05, 2026 (GLOBE NEWSWIRE) -- HealthVerity, Inc., the leader in privacy-protected real-world data exchange and patient identity solutions, today announced that it has entered into...
DUBLIN--(BUSINESS WIRE)--ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results.
DUBLIN & COLUMBIA, Md.--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, and Advarra, the market leader in regulatory reviews and a leading provider of connect...
NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating ICON PLC (“ICON” or the “Company”) (NASDAQ:...
Below estimates were sourced from SimplyWallSt and are intended for educational purposes only as a baseline for the analysis.
| Year | FCF Estimate | % | # Analysts |
|---|---|---|---|
| 2025 | 1.41B | -28.07% | Est @-28.1% |
| 2026 | 0.86B | -39.02% | Analyst x7 |
| 2027 | 0.90B | 5.06% | Analyst x8 |
| 2028 | 1.04B | 14.60% | Analyst x5 |
| 2029 | 1.05B | 1.65% | Analyst x2 |
| 2030 | 1.15B | 9.17% | Analyst x2 |
| 2031 | 1.20B | 4.62% | Est @4.6% |
| 2032 | 1.25B | 4.03% | Est @4.0% |
| 2033 | 1.30B | 3.61% | Est @3.6% |
| 2034 | 1.34B | 3.11% | Est @3.1% |
Below are the FCF estimates with the discount factor and the calculated present value with the terminal value that led the results above.
| Year | FCF | Discount Factor | PV of Future FCF |
|---|---|---|---|
| 2023A | 1.65B | 1.00 | 1.65B |
| 2024A | 1.96B | 1.00 | 1.96B |
| 2025E | 1.41B | 1.09 | 1.30B |
| 2026E | 859.71M | 1.18 | 725.90M |
| 2027E | 903.21M | 1.29 | 700.78M |
| 2028E | 1.04B | 1.40 | 737.94M |
| 2029E | 1.05B | 1.53 | 689.29M |
| 2030E | 1.15B | 1.66 | 691.47M |
| 2031E | 1.20B | 1.81 | 664.74M |
| 2032E | 1.25B | 1.97 | 635.43M |
| 2033E | 1.30B | 2.14 | 605.00M |
| 2034E | 1.34B | 2.33 | 573.21M |
| Terminal | 21.64B | 2.33 | 9.29B |
The information given by Studying Stocks and provided in the web and/or mobile applications (Platforms) is only factual information and should not be considered financial advice.
Any information contained in this website has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
When creating an account, you acknowledge that you are:
We retain the right to cancel your account for any reason, or refuse your account creation request.
The information on our Platforms is not comprehensive and is intended to provide a summary of the subject matter covered. While we use all reasonable attempts to ensure the accuracy and completeness of the data and information on our Platforms, to the extent permitted by law, we make no warranty regarding the information on these Platforms. You should monitor any changes to the information contained on these Platforms.
Furthermore we make no commitments in regards to the minimum amount of uptime that our platforms will maintain, although we will make ever reasonable attempt to ensure that the platforms are operational. Therefore, any reference of "latest", "current" and related words about the financial data presented here may not be up to date with the financial markets or represent reality of the information.
We are not liable to you or anyone else if interference with or damage to your computer systems occurs in connection with the use of these Platforms or a linked website. You must take your own precautions to ensure that whatever you select for your use from our Platforms is free of viruses or anything else (such as worms or Trojan horses) that may interfere with or damage the operations of your computer systems.
We may, from time to time and without notice, change or add to the Platforms (including the Terms) or the information, products or services described in it. However, we do not undertake to keep the Platforms updated. We are not liable to you or anyone else if errors occur in the information or the Platforms is not up-to-date.
Our Platforms may contain links to websites operated by third parties. Those links are provided for convenience and may not remain current or be maintained. Unless expressly stated otherwise, we do not endorse and are not responsible for the content on those linked websites and have no control over or rights in those linked websites.
These Platforms are for your personal, non-commercial use only. You may not modify, copy, distribute, transmit, display, perform, reproduce, publish, license, commercially exploit, create derivative works from, transfer, or sell any Content, software, products or services contained within these Platforms. You may not use these Platforms, or any of its Content, to further any commercial purpose, including any advertising or advertising revenue generation activity on your own website.
You must not do any act that we would deem to be inappropriate, is unlawful or is prohibited by any laws applicable to these Platforms, including but not limited to:
If we allow you to post any information to our Platforms, we have the right to take down this information at our sole discretion and without notice.
To the maximum extent permitted by law, we make no warranties or representations about these Platforms or the Content, including but not limited to warranties or representations that they will be complete, accurate or up-to-date, that access will be uninterrupted or error-free or free from viruses, or that these Platforms will be secure.
We reserve the right to restrict, suspend or terminate without notice your access to these Platforms, any Content, or any feature of these Platforms at any time without notice and we will not be responsible for any loss, cost, damage or liability that may arise as a result.
To the maximum extent permitted by law, in no event shall we be liable for any direct and indirect loss, damage or expense – irrespective of the manner in which it occurs – which may be suffered due to your use of our Platforms and/or the information or materials contained on it, or as a result of the inaccessibility of these Platforms and/or the fact that certain information or materials contained on it are incorrect, incomplete or not up-to-date.
This website utilises cookies. If you do not have cookies enabled in your web browser some functions of the site may not work as intended.
